Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
African Swine Fever vaccine (US Biologic)
- Development stage
- Preclinical
- Lead developer
- US Biologic
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
US Biologic is developing an oral vaccine for African Swine Fever (ASF) using its proprietary OrisBio platform. This platform utilizes *Bacillus subtilis* (*B. subtilis*) spores engineered to express specific African Swine Fever Virus (ASFV) antigens. When administered orally, these spores act as a delivery vehicle to the swine's gut-associated lymphoid tissue (GALT), where they elicit a protective immune response. The program is being developed in collaboration with the Department of Homeland Security (DHS) Plum Island Animal Disease Center and is currently in the preclinical stage of development.
- Other names
- ASFV oral vaccineOrisBio ASFV vaccineAfrican Swine Fever Virus (ASFV) oral vaccine
02
Targets
ASFV (African swine fever virus)
Beyond the preview
Go deeper on African Swine Fever vaccine (US Biologic).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on African Swine Fever vaccine (US Biologic).